CapVest seeks to move Curium into a large CV-on-CV

The buyout firm moved Curium Pharma into a €1.2bn single-asset continuation fund in 2020.

BySilas Sloan andMadeleine Farman

29 July 2025•2 mins read

Deals Western Europe Secondaries Single Assets Featured GP-Leds

Related articles

alt

Neuberger Berman leads Providence’s single-asset CV

9 hours ago · 2 mins read

alt

Behind the $400m CFO formed by Churchill and Temasek’s Seviora

20 August 2026 · 5 mins read

alt

ICG backs Onex’s Ryan again in CV-on-CV process

19 August 2026 · 2 mins read

alt

Hollyport backs Viking Growth’s €160m CV for Talentech

18 August 2026 · 2 mins read

alt

Apollo, Pantheon and SQ Capital co-lead on Exponent’s €750m CV

11 August 2026 · 2 mins read

alt

Pantheon backs BlackRock BDC’s credit CV

6 August 2026 · 2 mins read

alt

MetLife closes $1.2bn managed fund deal with Lexington

4 August 2026 · 3 mins read

motif